These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 32493238)
21. Prognostic Value of the Volumetric Parameters of Dual-Time-Point Okazaki E; Seura H; Hasegawa Y; Okamura T; Fukuda H AJR Am J Roentgenol; 2019 Dec; 213(6):1366-1373. PubMed ID: 31509426 [No Abstract] [Full Text] [Related]
22. Total metabolic tumor volume by 18F-FDG PET/CT for the prediction of outcome in patients with non-small cell lung cancer. Pellegrino S; Fonti R; Mazziotti E; Piccin L; Mozzillo E; Damiano V; Matano E; De Placido S; Del Vecchio S Ann Nucl Med; 2019 Dec; 33(12):937-944. PubMed ID: 31612416 [TBL] [Abstract][Full Text] [Related]
23. Lymph node standardized uptake values at pre-treatment Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776 [TBL] [Abstract][Full Text] [Related]
24. Prognostic value of metabolic tumor volume of pretreatment Kumasaka S; Nakajima T; Arisaka Y; Tokue A; Achmad A; Fukushima Y; Shimizu K; Kaira K; Higuchi T; Tsushima Y BMC Med Imaging; 2018 Nov; 18(1):46. PubMed ID: 30477476 [TBL] [Abstract][Full Text] [Related]
25. (18)F-FDG PET/CT mean SUV and metabolic tumor volume for mean survival time in non-small cell lung cancer. Kurtipek E; Çayci M; Düzgün N; Esme H; Terzi Y; Bakdik S; Aygün MS; Unlü Y; Burnik C; Bekci TT Clin Nucl Med; 2015 Jun; 40(6):459-63. PubMed ID: 25742234 [TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of volume-based 18F-FDG PET/CT parameter in patients with surgically resected non-small cell lung cancer. Comparison with immunohistochemical biomarkers. Lee JY; Choi JY; Heo JH; Han J; Jang SJ; Kim K; Kim J; Shim YM; Kim BT Nuklearmedizin; 2016; 55(1):7-14. PubMed ID: 26875430 [TBL] [Abstract][Full Text] [Related]
27. The value of different Anwar H; Vogl TJ; Abougabal MA; Grünwald F; Kleine P; Elrefaie S; Nour-Eldin NA Ann Nucl Med; 2018 Dec; 32(10):687-694. PubMed ID: 30219989 [TBL] [Abstract][Full Text] [Related]
28. Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value. Satoh Y; Onishi H; Nambu A; Araki T Radiology; 2014 Jan; 270(1):275-81. PubMed ID: 24029640 [TBL] [Abstract][Full Text] [Related]
29. Relation between tumor FDG uptake and hematologic prognostic indicators in stage I lung cancer patients following curative resection. Jeong E; Hyun SH; Moon SH; Cho YS; Kim BT; Lee KH Medicine (Baltimore); 2017 Feb; 96(5):e5935. PubMed ID: 28151879 [TBL] [Abstract][Full Text] [Related]
30. Survival Prognostic Value of Morphological and Metabolic variables in Patients with Stage I and II Non-Small Cell Lung Cancer. Domachevsky L; Groshar D; Galili R; Saute M; Bernstine H Eur Radiol; 2015 Nov; 25(11):3361-7. PubMed ID: 25929940 [TBL] [Abstract][Full Text] [Related]
31. Mantziari S; Pomoni A; Prior JO; Winiker M; Allemann P; Demartines N; Schäfer M BMC Med Imaging; 2020 Jan; 20(1):7. PubMed ID: 31969127 [TBL] [Abstract][Full Text] [Related]
32. Prognostic value of FDG uptake in early stage non-small cell lung cancer. Hanin FX; Lonneux M; Cornet J; Noirhomme P; Coulon C; Distexhe J; Poncelet AJ Eur J Cardiothorac Surg; 2008 May; 33(5):819-23. PubMed ID: 18374589 [TBL] [Abstract][Full Text] [Related]
33. [Prognostic value of (18)F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) in extensive-stage small cell lung cancer]. Ding CY; Guo Z; Li YY; Li TR Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):828-834. PubMed ID: 29151289 [No Abstract] [Full Text] [Related]
34. Prognostic value of preoperative metabolic tumor volumes on PET-CT in predicting disease-free survival of patients with stage I non-small cell lung cancer. Lin Y; Lin WY; Kao CH; Yen KY; Chen SW; Yeh JJ Anticancer Res; 2012 Nov; 32(11):5087-91. PubMed ID: 23155285 [TBL] [Abstract][Full Text] [Related]
35. A Pilot Study of Texture Analysis of Primary Tumor [ Nakajo M; Jinguji M; Shinaji T; Aoki M; Tani A; Nakabeppu Y; Nakajo M; Sato M; Yoshiura T Mol Imaging Biol; 2019 Aug; 21(4):771-780. PubMed ID: 30397859 [TBL] [Abstract][Full Text] [Related]
36. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma]. Ding CY; Guo Z; Sun J; Yang WP; Li TR Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):528-533. PubMed ID: 30060362 [No Abstract] [Full Text] [Related]
37. Prognostic significance of metabolic parameters measured by Chang H; Lee SJ; Lim J; Lee JS; Kim YJ; Lee WW J Cancer Res Clin Oncol; 2019 May; 145(5):1361-1367. PubMed ID: 30900157 [TBL] [Abstract][Full Text] [Related]
38. 18F-FDG PET/CT of Non-Small Cell Lung Carcinoma Under Neoadjuvant Chemotherapy: Background-Based Adaptive-Volume Metrics Outperform TLG and MTV in Predicting Histopathologic Response. Burger IA; Casanova R; Steiger S; Husmann L; Stolzmann P; Huellner MW; Curioni A; Hillinger S; Schmidtlein CR; Soltermann A J Nucl Med; 2016 Jun; 57(6):849-54. PubMed ID: 26823566 [TBL] [Abstract][Full Text] [Related]
39. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer. Chen HH; Chiu NT; Su WC; Guo HR; Lee BF Radiology; 2012 Aug; 264(2):559-66. PubMed ID: 22692034 [TBL] [Abstract][Full Text] [Related]
40. Volume-Based Assessment With 18F-FDG PET/CT Improves Outcome Prediction for Patients With Stage IIIA-N2 Non-Small Cell Lung Cancer. Hyun SH; Ahn HK; Ahn MJ; Ahn YC; Kim J; Shim YM; Choi JY AJR Am J Roentgenol; 2015 Sep; 205(3):623-8. PubMed ID: 26295651 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]